Recombinant avipox virus and immunological use thereof
US5174993A · kind A · utility
149Cited by
6References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 14, 1990 |
| Grant date | Dec 29, 1992 |
| Priority date | — |
| Expiry date | Jun 14, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for inducing an immunological response in a vertebrate to a pathogen by inoculating the vertebrate with a synthetic recombinant avipox virus modified by the presence, in a non-essential region of the avipox genome, of DNA from any source which codes for and expresses an antigen of the pathogen. The present invention further provides a synthetic recombinant avipox virus modified by the insertion therein of DNA from any source, and particularly from a non-avipox source, into a non-essential region of the avipox genome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.